Wednesday June 21, 2023
Laboratory diagnostics – where after Covid?
Diagnostic labs saw massive growth during Covid. How has this changed the long-term outlook for the sector? For instance, has Covid enabled the sector to successfully build new relationships with government and public payors? This session also explores growth opportunities in outsourcing, new tech, verticalisation and emerging markets
Jerome Thill, CEO, Groupe Cerba Healthcare
Wolf Kupatt, CEO, Amedes
Staffan Ternstrom, COO Diagnostic Services, Medicover
Moderated by Martin Debenito-Gellner, Senior Analyst, HBI
Fleming - 3rd Floor
Explore similar sessions
Sector in focus: Lab diagnostics
With few consolidation opportunities remaining, the future for labs lies in organic growth and digitalisation. What will be the impact of automation and smart laboratories? Will self-testing take off massively?...
Sector in focus: Diagnostic imaging
This sector has seen a huge M&A boom as investors seek to consolidate Western Europe. governments are also pumping money into the sector to increase access to diagnosis and bring...
Panel Discussion: Partnering strategies
This session brings together a group of senior managers whose role is to promote and build partnerships in the university hospital ecosystem. How are university hospitals changing their approach to...